Bilateral Transplantation of Allogenic Adult Human Bone Marrow-Derived Mesenchymal Stem Cells into the Subventricular Zone of Parkinson’s Disease: A Pilot Clinical Study

Figure 2

Shows the mean ± SD of the UPDRS score of the PD patients during “OFF” and “ON” periods at baseline and after stem cell transplantation. The scores have been assessed during the screening visit and final visit 12 months after transplantation. *Represents the level of significance.